معرفی
Dr. Mehrnaz Keyhanfar serves as a Senior Lecturer at Flinders University's College of Medicine and Public Health (CMPH) since 2019, where she specializes in medical biochemistry and pharmacology education. Her academic journey spans international institutions with expertise in protein chemistry, drug delivery systems, and plant-derived therapeutics.
Her educational credentials include:
- Graduate Certificate in Clinical Education (2022), Flinders University
- PhD in Biotechnology/Biochemistry (2005), The University of Adelaide
- Pharm D (Pharmacy Doctorate) (1998), Isfahan University of Medical Sciences
Dr. Keyhanfar's research bridges molecular biochemistry with practical applications in disease diagnosis and targeted therapy. She investigates protein structure-function relationships, pharmaceutical biotechnology approaches for drug delivery, and plant secondary metabolite production for therapeutic use. Her work emphasizes translating molecular insights into clinical solutions for human diseases.
Analysis of her recent publications reveals a dominant focus on nanotechnology applications spanning 2017-2024. Key themes include antimicrobial nanoparticle development for aquaculture and medical device coatings, plant-based nanomaterial synthesis, and targeted cancer drug delivery systems. Her work consistently connects biochemical principles with practical solutions in pharmacology and biotechnology.
As an active educator, Dr. Keyhanfar serves as Topic Coordinator for Biochemistry of Human Disease and Molecular Foundations of Medicine courses while lecturing across multiple medical science programs. She contributes to institutional leadership as a Flinders Learning and Teaching Academy member, Academic Integrity Officer, and Australian Institute of Medical Scientists Accreditation Working Group leader.
Her professional engagement extends to the Teaching Specialist Community of Practice, Early and Mid-Career Academic Network, and Australian Society for Biochemistry and Molecular Biology, demonstrating commitment to both medical education advancement and biochemical research innovation.
